A detailed history of First Command Bank transactions in Novartis Ag stock. As of the latest transaction made, First Command Bank holds 100 shares of NVS stock, worth $10,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$10,381
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$80.11 - $90.62 $19,867 - $22,473
-248 Reduced 71.26%
100 $9,000
Q1 2021

Apr 20, 2021

SELL
$83.5 - $98.47 $21,877 - $25,799
-262 Reduced 42.95%
348 $29,000
Q1 2020

Apr 20, 2020

SELL
$70.67 - $99.01 $10,600 - $14,851
-150 Reduced 19.74%
610 $50,000
Q4 2019

Jan 14, 2020

BUY
$84.35 - $95.37 $11,049 - $12,493
131 Added 20.83%
760 $72,000
Q3 2019

Oct 15, 2019

BUY
$85.54 - $94.26 $20,444 - $22,528
239 Added 61.28%
629 $55,000
Q3 2017

Oct 10, 2017

BUY
$74.14 - $77.27 $28,914 - $30,135
390
390 $33,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First Command Bank Portfolio

Follow First Command Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Command Bank with notifications on news.